Clement Lewin is currently Associate Vice President Head BARDA Office and NV Stakeholder Engagement. He has been in the vaccines industry for over twenty years and joined Sanofi Pasteur in 2015. He is responsible for managing the company’s relationship with the US Department of Health and Human Services Biomedical Advanced Research and Development Authority BARDA focusing on pandemic preparedness as well as COVID-19 and supports engagement with external stakeholders. Clem obtained his BSc and PhD from the University of London. After 5 years as a Research Fellow at the Universities of London and Edinburgh. During that period he published over 50 papers in peer reviewed journals on mechanisms of action and resistance to antibacterials. He left research to obtain an MBA with distinction from Cornell University and then joined the life sciences practice of Pittiglio Rabin Todd & McGrath specializing in product development issues. Clem was the Biotechnology Industry Organization liaison to the Advisory Committee on Immunization Practices from 2004 to 2014. He served on the National Vaccine Advisory Committee from 2009-2012. He was on the advisory board of Bio Ventures for Global Health and a board member of the Alliance for Biosecurity. He currently serves on the Board of Trustees of Gaylord Hospital a long-term acute care facility in Connecticut.